The HERMIONE-2MAN project will pave the way to an outstanding & innovative approach of cancer treatment, offering great clinical and market potential.

The project

The HERMIONE project enabled the early development of an anti-Netrin-1 mAb, a promising anti-cancer drug candidate.

Read More

Potential impact

On patients and their quality of life, on public health, on Science, on European biotechnology research.

Read More

The objective

The objective of the current HERMIONE-2MAN project is to conduct a first-in-man clinical trial with a first-in-class bio-therapeutic agent.

Read More